Tag: Jack Mycka

Jack Mycka

Are you looking for timely recommendations to meet current challenges and identify opportunities during COVID-19? Are you seeking the best information about emerging trends in market access? Whatever questions you may have, we’re here to provide you with cutting-edge yet practical insights that leverage our 15 years in the business. Please take advantage of our expertise by reading the latest reports from our payer surveys and sign up for our newsletter to stay up to date. At MME, we are ready to support and solve your ongoing needs. 

What impact will Trump’s most-favored-nation approach have on US drug pricing?

October 20, 2020
Read More

An analysis of how Trump’s latest executive order will affect US drug pricing

September 14, 2020
Read More

What impact would International Reference Pricing have in the US?

August 25, 2020
Read More

Competitive impact has changed. Is your business ready?

August 4, 2020
Read More

A 10-year review (2009-2018) of market access of pharmaceuticals in the EU5 and US.

December 1, 2019
Read More

ISPOR Pricing Short Courses with Jack Mycka and Renato Dellamano at ISPOR Annual International Meeting May 2019

November 5, 2019
Read More

Market access trends across the EU5 and US: 2009 to 2018 – an update.

June 1, 2019
Read More

EU5 market access for medicines approved under exceptional circumstances.

December 1, 2018
Read More


Share on facebook
Share on twitter
Share on linkedin
Share on email

let's talk!

Medical Marketing Economics

1200 Jefferson Ave.
Suite 200
Oxford, MS 38655

Medical Marketing Economics

8 Hillside Ave
Suite 301
Montclair, NJ 07042